11
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 531-542 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • A liposome-forming caged compound: synthesis and photochemical properties of a caged L-leucyl-L-leucine methyl ester with a steroid skeleton. WATANABE, S., and IWAMURA, M., J. Org. Chem., 1997, 62(25), 8616–8617.
  • A new strategy to determine the actual protein content of poly (lactide-co-glycolide) micro-spheres. SAH, H., J. Pharm. Sci., 1997, 86(11), 1315–1318.
  • A second dose of a CFTR cDNA-liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea. GODDARD, C. A., RATCLIFF, R., ANDERSON, J. R., GLENN, E., BROWN, S., GILL, D. R., HYDE, S. C., MACVINISH, L. J., HUANG, L., HIGGINS, C. F., CUTHBERT, A. W., EVANS, M. J., and COLLEDGE, W. H., Gene They., 1997, 4(11), 1231–1236.
  • A novel separation technique with microcapsules. YAN, N., Miner. Process Extr. Metal. Rev., 1997, 17(14), 257–276.
  • A randomized comparison of liposomal versus conventional amphotericin B for the treat-ment of pyrexia of unknown origin in neutropenic patients. PRENTICE, H. G., HANN, I. M., HERBRECHT, R., AOUN, M., KVALOY, S., CATOVSKY, D., PINKERTON, C. R., SCHEY, S. A., JAcous, F., OAKFHLL, A., STEVENS, R. F., DARBYSHIRE, P. J., and GIBSON, B. E., 137. y. Haematol., 1997, 98(3), 711–718.
  • Activation of a retroviral membrane fusion protein: soluble receptor-induced liposome binding of the ALSV envelope glycoprotein. HERNANDEZ, L. D., PETERS, R. J., DELOS, S. E., YOUNG, J. A., AGARD, D. A., and WHITE, J. M., J. Cell. Biol., 1997, 139(6), 1455–1464.
  • Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. WALLACE, T. L., PAETZNICK, V., COSSUM, P. A., LOPEZ-BERESTEIN, G., REX, J. H., and ANAISSIE, E., Antimicrob. Agents Chemother., 1997, 41(10), 2238–2243.
  • Adsorption of protein on the surface of thermosensitive poly(methyl methacrylate) micro-spheres modified with the N-(2-hydroxypropyl) methacrylamide and 2-(methacryloy-loxy)ethyl phosphorylcholine moieties. SUG1YAMA, K., MITSUNO, S., and SHIRAISHI, K., J. Polym. Sci., Part A: Polym. Chem., 1997, 35(16), 3349–3357.
  • Aggregation, fusion and aqueous content release from liposomes induced by lysozyme derivatives: effect of the lytic activity. VECHETTI, G. F., DE ARCURI, B. F., POSSE, E., ARRONDO, J. L. R., and MORERO, R, D., Mol. Membr. Biol., 1997, 14(3), 137–142.
  • Alanine mutagenesis of surfactant protein A reveals that lipid binding and pH-dependent liposome aggregation are mediated by the carbohydrate recognition domain. McCoa-MACK, F. X., STEWART, J., VOELKER, D. R., and DAMODARASAMY, M., Biochemistry, 1997, 36(45), 13 963–13 971.
  • Antigen incorporation into liposomes results in the enhancement of IL-4 and IgG1 secretion: evidence for preferential expansion of Th-2 cells. AGREWALA, J. N., OWAIS, M., GUPTA, C. M., and MISHRA, G. C., Cytokines. Mol. Ther., 1996, 2 (I ), 59–65.
  • Antioxidant activity of grape extracts in a lecithin liposome system. 171,0. S., MEYER, A. S., and FRANKEL, E. N., I. Am. Oil Chem. Soc., 1997, 74(10), 1301–1307.
  • Antioxidant effects of L-carnosine on liposomes and beef homogenates. LEE, B. J., and HENDRICKS, D. G., y. Food Sci., 1997, 62(5), 931–934. 1000.
  • Antitumor activity of recombinant human tumor necrosis factor-alpha (rH-TNF alpha) and liposome-entrapped rH-TNF alpha. WAKABAYASHI, T., YOSHIDA, J., ISHIYAMA, J., and MIZUNO, M., Neurol. Med. Chir. (Tokyo), 1997, 37(10), 739–745; discussion 745–746.
  • Application of lipid microspheres containing prostaglandin El ointment to peripheral ischemic ulcers. SAKAKIBARA, Y., JIKUYA, T., and MITSUI, T., Dermatology, 1997, 195 (3), 253–257.
  • Application of polymers in microencapsulation. CHEN, Q., Zhongguo Yiyao Gongye Zazhi, 1997, 28(4), 191–194.
  • Architecture of polymeric superstructures formed by locking cubic lattices of core-shell polymer microspheres. ISHIZU, K., IKEMOTO, T., and Iciiimuas, A., Polymer, 1997, 39(2), 449–454. 1998.
  • Behavior of copper in copper microencapsulated hydrogen storage alloy electrode. ZHANG, D., YUAN, H., YANG, H., ZHOU, Z., and ZHANG, Y., Dianhuaxue, 1997, 3(3), 263–270.
  • Bioadhesive microspheres for ophthalmic administration of acyclovir. GENTA, I., CONTI, B., PERUGIN1, P., PAVANETTO, F., SPADARO, A., and PUGLISI, G., J. Pharm. Pharmacol., 1997, 49(8), 737–742.
  • Bioavailability of microencapsulated ferrous sulfate in fluid milk studies in human beings. GOTELLI, C. A., GOTELLI, M. J., Bocci°, J. R., ZUBILLAGA, M. B., CARO, R. A., GARCIA DEL RIO, H, and WEILL, R., Acta Physiol. Pharmacol. Ther. Latinoam., 1996, 46(4), 239–245.
  • Biodegradation and biocompatibility of PLA and PLGA microspheres. ANDERSON, J. M., and SHIVE, M. S., Adv. Drug Delivery. Rev., 1997, 28(1), 5–24.
  • Biodistribution of cyclosporin encapsulated in liposomes modified with bioadhesive poly-mer. YOSHIKAWA, Y., MIYAZAKI, M., HOUJOU, T., KOMUTA, Y., YOSHIKAWA, H., and TAKADA, K., J. Pharm. Pharmacol., 1997, 49(7), 661–668.
  • Biological activity of lysozyme after entrapment in poly(Dx-lactide-glycolide) microspheres. GHADERI, R., and CARLFORS, J., Pharm. Res., 1997, 14(11), 1556–1562.
  • Biophysical and antigenic characterization of gonococcal protein I incorporated into lipo-somes. PAR1VIAR, M. M., BLAKE, M. S., and MADDEN, T. D., Vaccine, 1997, 15(15), 1641–1651.
  • Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxyl radicals: relationship between carotenoid structure and protective ability. WOODALL, A. A., BarrroN, G., and JACKSON, M. J., Biochim. Biophys. Acta, 1997, 1336(3), 575–586.
  • Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1. ISHII, N., FUKUSHIMA, J., KANEKO, T., OKADA, E., TANI, K., TANAKA, S., HAMAJIMA, K., XIN, K. Q., Kawamo-ro, S., Ko, W., N1SHIOKA, K., YASUDA, T., and OKUDA, K., AIDS Res. Hum. Retroviruses, 1997, 13(16), 1421–1428.
  • Cationic liposome-plasmid DNA complexes used for gene transfer retain a significant trapped volume. WASAN, E. K., FAIRCHILD, A., and BALLY, M. B., J. Pharm. Sc., 1998, 87(1), 914.
  • Cellular retention of liposome-delivered anionic compounds modulated by a probenecid-sensitive anion transporter. OH, Y. K., and STRAUBINGER, R. M., Pharm. Res., 1997, 14(9), 1203–1209.
  • Characterization and stability of various liposome-encapsulated enoxacin formulations. FANG, J. Y., LIN, H. H., Hsu, L. R., and TSAI, Y. H., Chem. Pharm. Bull. (Tokyo), 1997, 45 (9), 1504–1509.
  • Characterization of poly(glycolide-co-DL-lactide)/poly(DL-lactide) microspheres for con-trolled release of GM-CSF. PETTIT, D. K., LAWTER, J. R., HUANG, W. J., PANKEY, S. C., NIGHTLINGER, N. S., LYNCH, D. H., SCHUH, J. A. C. L., MORRISSEY, P. J, and GOMBOTZ, W. R., Pharm. Res., 1997, 14(10), 1422–1430.
  • Characterization of ciprofioxacin liposomes: derivative ultraviolet spectrophotometric deter- minations. Gummi', A., and SENYUCEL, B., J. Microencapsulation, 1997, 14(6), 769–776.
  • Characterization of cationic liposome-mediated gene transfer in vivo by intravenous admin- istration. SONG, Y. K., Liu, F., CHU, S., and Liu, D., Hum. Gene Ther., 1997, 8(13), 1585–1594.
  • Characterization of modified alginate-poly-L-lysine microcapsules. LEE, C. S., and Cuu, I. M., Artif. Organs, 1997, 21(9), 1002–1006.
  • Chemotherapy targeting regional lymph nodes by gastric submucosal injection of liposomal adriamycin in patients with gastric cancer. AKAMO, Y., MIZUNO, I., TAKEYAMA, H., MOHR, N., UEDA, T., SHIBATA, T., YOTSUYANAGI, T., and MANABE, T., Gan. To. Kagaku. Ryoho., 1997, 24(12), 1712–1714.
  • Chitosan microspheres with hydrocortisone: improvement of dissolution rate. FILIPOVIC, G. J., BECIREVIC, L. M., and JALSENJAK, I., Farm Vestn (Ljubljana), 1997, 48 (Pos. Stev.), 316–317.
  • Chronic local tissue reactions, long term immunogenicity, and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer micro-spheres composed of poly (lactide-co-glycolide) polymers. GUPTA, R. K., ALROY, J., ALONSO, M. J., LANGER, R., and SIBER, G. R., Vaccine, 1997, 15(16), 1716–1723.
  • Clinical and microbiological effects of minocycline-loaded microcapsules in adult period-ontitis. YEOM, H. R., PARK, Y. J., LEE, S. J., RHYU, I. C., CHUNG, C. P., and NISENGARD, R. J., y. Periodontol., 1997, 68(11), 1102–1109.
  • Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers. MUGGIA, F. M., Drugs, 1997, 54 (Suppl. 4, Disease Management of Solid Tumours and the Emerging Role of Pegylated Liposomal Doxorubicin), 22–29.
  • Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. FRITH, J. C., MONKKONEN, J., BLACKBURN, G. M., RUSSELL, R. G., and ROGERS, M. J., J. Bone Miner. Res., 1997, 12(9), 1358–1367.
  • Comparative efficacy and tolerability of econazole liposomal gel 1%, branded econazole conventional cream 1% and generic clotrimazole cream 1% in tines pedis. KORTING, H. C., KLOVEKORN, W., KLOVEKORN, G., and Ecosom COLLABORATIVE STUDY GROUP., Clin. Drug. Invest., 1997, 14(4), 286–293.
  • Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration. TRISSEL, L. A., GILBERT, D. L. and MARTINEZ, J. F. Am. J. Health Syst. Pharm., 1997, 54(23), 2708–2713.
  • Cryopreservation of microencapsulated porcine pancreatic islets: in vitro and in vivo studies. ZHOU, D., VACEK, I., and SUN, A. M., Transplantation, 1997, 64(8), 1112–1116.
  • CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice. WEBER, C. J., HAGLER, M. K., CHRYSSOCHOOS, J. T., KAPP, J. A., KORBUTT, G. S., RAJOYEE, R. V., and LINSLEY, P. S., Cell Transplant, 1997, 6(5), 505–508.
  • Decomposition of H202 by microencapsulated catalase. Liu, C. B., HUANG, K., SHE, Y. M., SHAN, Y. K., and WANG, Y. J., Shengwu Huaxue Zazhi, 1997, 13(4), 478–482.
  • Decreasing the combustibility of polycaproamide and poly(ethylene terephthalate) introdu-cing polymer microencapsulated fireproofing agents. ZUBKOVA, N. S., TYUGANOVA, M. A., BOROVKOV, N. Y., and MORYGANOV, A. P., Khim. Volokna, 1995, (5), 40–43.
  • Determination of liquid-crystalline transition temperature of temperature-sensitive lipo-somes of futraful by 1HNMR. ZHANG, C., JIANG, X., and YANG, G., Yaoxue Xuebao, 1997, 32(1), 69–71.
  • Determination of the entrapment rate of ofloxacin liposomes by fluorospectrophotometry. MA, S., and Li, M., Yaowu Fenxi Zazhi, 1997, 17(3), 179–181.
  • Determination of polyethylene glycol activated with cyanuric chloride in liposomes. BOADA, J., GALLARDO, M., and ESTELRICH, J., Anal. Biochem., 1997, 253(1), 33–36.
  • Development of vegetable extracts by microencapsulation. RIBEIRO, A., ARNAUD, P., FRAZAO, S., VENANCIO, F., and CHAUMEIL, J. C., J. Microencapsulation, 1997, 14(6), 735–742.
  • Drug release from microspheres adhered on intact and damaged vesical mucosa. BOGATAJ, M., BURJAK, M., and MRHAR, A., Farm Vestn. ( Ljubljana), 1997, 48 (Pos. Stev.), 224–225.
  • Dye-incorporated poly(EGDMA-HEMA) microspheres as specific sorbents for aluminum removal. DENIZLI, A., SALM, B., KAVAKLI, C., and PIGSKIN, E., J. Chromatogr. B. Biomed. Sci. Appl., 1997, 698 (12), 89–96.
  • Dyeing of polyester-wool blends using liposomes. MARTI, I. G. M., Rev. Quim. Text, 1997, 134, 30–32. 34–36. 38–40. 42–44. 46–47.
  • Effect of sodium chloride, chlorite, and perchlorate on the hypochlorite-induced peroxida-tion of phospholipid liposomes. PANASENKO, 0. M., ARNHOLD, J., and SERGIENKO, V. I., Membr. Cell Biol., 1997, 11(2), 253–258.
  • Effect of aluminium ions on liposomal membranes as detected by Laurdan fluorescence. DOUSSET, N., FERRETTI, G., GALEAZZI, T., TAUS, M., GOUAZE, V., BERTHON, G., and CURATOLA, G., Free Radic. Res., 1997, 27(3), 291–299.
  • Effect of gamma irradiation on microspheres containing anticancer drug. YOSHIZAWA, H. YAMASHITA, S. UEMURA, Y., SHIMADA, M., NAKAMURA, K., AIKO, T., and HATATE, Y., Kagoshima Daigaku Kogakubu Kenkyu Hokoku, 1997, 39, 107–109.
  • Effect of glass micropellets and microspheres on the water sorption of an epoxy coating. KOTNAROWSKA, D., Ochr Koroz, 1997, 40(9), 259–262.
  • Effect of IL-4 and IL-12 liposomal formulations on the induction of immune response to bovine herpesvirus type-1 glycoprotein D. BACA, E. M. E., FOLDVARI, M., SNIDER, M., VAN DRUNEN, L., VAN DEN HURK, S., and BABIUK, L. A., Vaccine, 1997, 15(16), 1753–1760.
  • Effect of long-term parenteral administration of empty, and L-Dopa-loaded liposomes on the turnover of dopamine and its metabolites in the striatum of mice with experimental Parkinson's syndrome. YURASOV, V. V., KUCHERYANU, V. G., KUDRIN, V. S, ZHIGAL-TSEV, I. V., NIKUSHKIN, E. V., SANDALOV, Y. G., KAPLUN, A. P., and SHVETS, V. I., Bull. Exp. Biol. Med. ( Transl. of Byull. Eksp. Biol. Med.), 1997, 123(2), 126–129.
  • Effect of microencapsulation on immunogenicity of a bovine herpes virus glycoprotein and inactivated influenza virus in mice. MOSER, C. A., SPEAKER, T. J., and OFFIT, P. A., Vaccine, 1997, 15(16), 1767–1772.
  • Effect of microsphere size distribution on the ultrasonographic contrast efficacy of air-filled albumin microspheres in the left ventricle of dog hearts. SONTUM, P. C., WALDAY, P., DYRSTAD, K., HoFF, L., FRIGSTAD, S., and CHISTIANSEN, C., Invest. Radio., 1997, 32(10), 627–635.
  • Effect of N-acyl-phosphatidylethanolamine on the membrane fusion between Sendai virus and liposome. OGAWA, Y., and EPAND, R. M., Biosci. Rep., 1997, Aug, 17(4), 401–408.
  • Effect of serum components from different species on destabilizing hydrogenated phospha-tidylcholine-based liposomes. Liu, S., ISHIDA, T., and KIWADA, H., Biol. Pharm. Bull., 1997, 20(8), 874–880.
  • Effect of the size of liposomes on the transfer and uptake of carboxyfluorescein by the perfused human term placenta. BAJORIA, R., and CONTRACTOR, S. F., J. Pharm. Pharmacol., 1997, 49(7), 675–681.
  • Effect of freezing rate on the stability of liposomes during freeze-drying and rehydration. VAN WINDEN, E. C., ZHANG, W., and CROMMELIN, D. J., Pharm. Res., 1997, 14(9), 1151–1160.
  • Effect of the slimming agent oleoyl-estrone in liposomes on the body weight of Zucker obese rats. BALADA, F., SANCHIS, D., GRASA, M. M., VIRGIL, J., ESTRUCH, J., FERNANDEZ LOPEZ, J. A., REMESAR, X., and ALEMANY, M., hit. 9. Obes. Re/at. Metab. Disord., 1997, 21(9), 789–795.
  • Effect of dicetylphosphate or stearic acid on spontaneous transfer of protein from influenza virus-infected cells to dimyristoylphosphatidylcholine liposomes. KOGURE, K., NAKA MURA, C., OKUDA, 0., HAYASHI, K., and UENO, M., Biochim. Biophys. Acta, 1997, 1329(1), 174–82.
  • Effect of liposomal L-Dopa on Parkinson's syndrome in mice. KUCHERYANU, V. G., YURASOV, V. V., KRYZHANOVSKII, G. N., NIKUSHKIN, E. V., ZHIGAL-TSEV, I. V., KAPLUN, V. P., and SHVETS, V. I., Bull. Exp. Biol. Med. (Transl. of Byull. Eksp. Biol. Med.), 1997, 123(1), 24–27.
  • Effect of surface charge of small unilamellar liposomes on uptake and transfer of carboxy-fluorescein across the perfused human term placenta. BAJORIA, R., and CONTRACTOR, S. F., Pediatr. Res., 1997, 42(4), 520–527.
  • Effects of different core densities on the diffusibility of microspheres. SAITO, R., and Isnizu, K., Polymer, 1997, 39(2), 335–338. 1998.
  • Effects of microcapsulated docosahexaenoic acid preparation on properties of dough and bread. MORITA, N., and SHIRAI, J., 9. Nutr. Sci. Vitaminol., 1997, 43(5), 591–600.
  • Effects of interferon-alpha liposome on lung metastasis of Lewis lung carcinoma and proliferation of splenocytes in mice. XIE, J., Juk, Z., REN, J., CHEN, Y., and Wu, B., Zhongguo Shenghua Yaowu Zazhi, 1997, 18(4), 174–177.
  • Effects of positive charge density on the liposomal surface on disposition kinetics of liposomes in rats. Amu, H., Torrom, T., SAKURAI, F., Fuji, K., and MIYAJIMA, K., Int. 5. Pharm., 1997, 156(2), 163–174.
  • Effects of the isocarbacyclin methyl ester clinprost incorporated into lipid microspheres, in focal ischemia of stroke-prone spontaneously hypertensive rats. YAC, T., ARAKI, H., 0-oGAmi, Y., IWASAKI, K., TANABE, H., and FujiWARA, M., Arzneim. Forsch., 1997, 47(11), 1200–1203.
  • Effects of clodronate-containing liposomes on testicular macrophages and Leydig cells in vitro. BRIGHAM, D. E., LITTLE, G., LUKYANENKO, Y. 0., and HUTSON, J. c., y. Endocrinol., 1997, 155(1), 87–92.
  • Efficacy of deoxycholate amphotericin B and unilamellar liposomal amphotericin B in prophylaxis of experimental Aspergillus fumigatus endocarditis. MYLONAKIS, E., CHALEVELAKIS, G., SAROGLOU, G., DANIAS, P., ARGYROPOULOU, A. D., PANIARA, 0., and RAPTIS, S. A., Mayo Clin. Proc., 1997, 72(11), 1022–1027.
  • Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic lipo-some and HVJ-liposome. SATOH, E., OSAWA, M., TOMIYASU, K., HIRAI, H., SHIMAZAKI, C., ODA, Y., NAKAGAWA, M., KONDO, M., KINOSHITA, S., MAZDA, 0., and IMANISHI, J., Biochem. Biophys. Res. Commun., 1997, 238(3), 795–799.
  • Efficient transfer of synthetic ribozymes into cells using hemagglutinating virus of Japan (HVD-cationic liposomes. Application for ribozymes that target human t-cell leukemia virus type I tax/rex mRNA. KITAJIMA, I., HANYU, N., SOEJIMA, Y., HiaANo, R., ARAHIRA, S., YAMAOKA, S., YAMADA, R., MARUYAMA, I., and KANEDA, Y.,7. Biol. Chem., 1997, 272 (43), 27 099–27106.
  • Electron microscopic demonstration of the interaction of liposomes and cells in vitro. SCIiRAMLOVA, J., BLAZEK, K., DANIELOVA, V., BARTACKOVA, M., HOLUBOVA, J., OTOVA, B., and HULINSKA, D., Folio. Biol. ( Praha), 1997, 43(4), 161–164.
  • Electron microscopic demonstration of the penetration of liposomes through skin. SCHRAM-LOVA, J., BLAZEK, K., BARTACKOVA, M., OTOVA, B., MARDESICOVA, L., ZIZKOVSKY, V., and HULINSKA, D., Folio. Biol. (Praha), 1997, 43(4), 165–169.
  • Electrorotation of liposomes: verification of dielectric multi-shell model for cells. CHAN, K. L., GASCOYNE, P. R., BECKER, F. F., and PETHIG, R., Biochim. Biophys. Acta, 1997, 1349 (2), 182–196.
  • Electrostatic parameters of cationic liposomes commonly used for gene delivery as deter-mined by 4-heptadecy1-7-hydroxycoumarin. ZUIDAM, N. J., and BARENHOLZ, Y Biochim. Biophys. Acta, 1997, 1329 (2), 211–222.
  • Encapsulation of calcitonin in liposomes depends on the vesicle preparation method. ARIEN, A., and DUPUY, B., 9. Microencapsul., 1997, 14(6), 753–760.
  • Enhanced permeability of freeze-dried liposomal bilayers upon rehydration. ZHANG, W., VAN WINDEN, E. C. A., BOUWS'I'RA, J. A., and CROMMELIN, D. J. A., Cryobiology, 1997, 35(3), 277–289.
  • Enhanced pulmonary accumulation of liposomal amphotericin B (Am Bisome) in acute liver transplant failure. HEINEMANN, V., BOSSE, D., JEHN, U., DEBUS, A., WACHHOLZ, K., FORST, H., and WILNIANNS, W., 9. Antimicrob. Chemother., 1997, 40(2), 295–297.
  • Enhanced anticancer therapy mediated by specialized liposomes. DASS, C. R., WALKER, T. L., BURTON, M. A., and DECRUZ, E. E., 9. Pharm. Pharmacol., 1997, 49(10), 972–975.
  • Enhancement of the in vivo circulation lifetime of L-alpha-distearoylphosphatidylcholine liposomes: importance of liposomal aggregation versus complement opsonization. AIIL, P. L., BHATIA, S. K., MEERS, P., ROBERTS, P., STEVENS, R., DAUSE, R., PERKINS, W. R., and JANo, A. S., Biochim. Biophys. Acta, 1997, 1329 (2), 370–382.
  • Enhancing effect of cholesterol on the elimination of liposomes from circulation is mediated by complement activation. ISHIDA, T., FUNATO, K., KOJIMA, S., YODA, R., and KIWADA, H., Int.J. Pharm., 1997, 156(1), 27–37.
  • Entrapment of nucleic acids in liposomes. MONNARD, P. A., OBERHOLZER, T., and Luis', P., Biochim. Biophys. Acta, 1997, 1329(1), 39–50.
  • Error associated with the choice of an aortic cannula in measuring regional cerebral blood flow with microspheres during pulsatile CPB in a neonatal piglet model. UNDAR, A., LODGE, A. J., DAGGETT, C. W., RUNGE, T. M., UNGERLEIDER, R. M., and CALHOON, J. H., ASAIO1997, 43(5), M482–M486.
  • Estimation of surface state of poly(ethylene glycol)-coated liposomes using an aqueous two-phase partitioning technique. MORIBE, K., MARUYAMA, K., and IWATSURU, M., Chem. Pharm. Bull. (Tokyo), 1997, 45(10), 1683–1687.
  • Experimental study on 5-fluorouracil microspheres. Preparation and therapeutic effect on peritoneal carcinomatosis. YAMASAKI, J., Kyoto furitsu Ika Daigaku Zasshi, 1997, 106 (11), 1091–1098.
  • Expression of chemokine receptors by endothelial cells: detection by intravital microscopy using chemokine-coated fluorescent microspheres. FINGAR, V. H., Guo, H. H., Lu, Z. H., and PEIPER, S. C., Methods Enzymol., 1997, 288, 148–158.
  • Experimental study of nimodipine effect on inner ear microcirculation in guinea pigs with noise-induced deafness by radioactive microsphere technic. ZHOU, H., and YANG, J., Shaanxi Yixue Zazhi, 1997, 26(2), 125–126.
  • Extraction of uranyl ions with polyurea microcapsules. NI, P., ZHANG, M., CHEN, M., and YAN, N., Gaoxiao Huaxue Gongcheng Xuebao, 1997, 11(3), 323–326.
  • Fabrication of microspheres using blends of poly(ethylene adipate) and poly(ethylene adipate)/poly(hydroxybutyrate-hydroxyvalerate) with poly(caprolactone): incorpora-tion and release of bovine serum albumin. ATKINS, T. W., y. Biomater. Sci. Polym. Ed., 1997, 8(11), 833–845.
  • Fabrication of Li2Zr03 microsphere by sol-gel method. WANG, H., SUN, Y., ZHAO, J., and Fu, Y Gaojishu Tongxun, 1997, 7(8), 53–57.
  • Focal delivery of neurotrophins into the central nervous system using fluorescent latex microspheres. RIDDLE, D. R., KATZ, L. C., and Lo, D. C., BioTechniques, 1997, 23(5), 928–930. 932–934. 936–937.
  • Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting. SHIMIZU, K., MAITANI, Y TAKAYAMA, K., and NAGAI, T., Biol. Pharm. Bull., 1997, 20(8), 881–886.
  • Formulation and antitumor efficacy of liposomal-caprylated-TNF-SAM2. AKIMARU, K., AUZENNE, E., AKIMARU, Y., LEROUX, M. E., HAYMAN, A. C., UTSUMI, T., SOMA, G., and KLOSTERGAARD, J., Cytokines. Mol. Ther., 1995, 1(3), 197–210.
  • Formulation and evaluation of colon-targeted tegafur microspheres. MOHAMED, F. A., EL-GENDY, G. A., and Au, A. S., Bull. Pharm. Sci., Assiut. Univ., 1997, 20(1), 9–15.
  • Gamma-irradiation damage to liposomes differing in composition and their protection by nitroxides. SAmuNI, A. M., BARENHOLZ, Y., CaommEuN, D. J., and ZUIDAM, N. J., Free Radic. Biol. Med., 1997, 23(7), 972–979.
  • Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma. MABUCHI, E., Solmizu, K., MIYAO, Y., KANEDA, Y., KISHIMA, H., TAMURA, M., IKENAKA, K., and HAYAKAWA, T., Gene Ther., 1997, 4(8), 768–772.
  • Gene transfer into the carotid artery using an adventitial collar: comparison of the effec-tiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and a denoviruses. LAITINEN, M., PAKKANEN, T., DoNETTI, E., BAETTA, R., LUOMA, J., LEHTOLAINEN, P., VIITA, H., AGRAWAL, R., MIYANOHARA, A., FRIEDMANN, T., RISAU, W., MARTIN, J. F., SomA, M., and YLA-HERTTUALA, S., Hum. Gene. Ther., 1997, 8(14), 1645–1650.
  • Growth and fatty acid composition of Pacific oyster (Crassostrea gigas) spat fed a spray-dried freshwater microalga (Spongiococcum excentricum) and microencapsulated lipids. KNAUER, J., and SOUTHGATE, P. C., Aquaculture, 1997, 154 (3,4), 293–303.
  • Growth inhibitory effects of liposome-associated 1-0-octadecy1-2-0-methyl-sn-glycero-3-phosphocholine. PETERS, A. C., AHMAD, 1., JANOFF, A. S., PUSHKAREVA, M. Y., and MAYHEW, E., Lipids, 1997, 32(10), 1045–1054.
  • Heat-expandable microspheres for car protection production. TOMALINO, M., and BIANCHINI, G., Prog. Org. Coat., 1997, 32 (14), 17–24.
  • High-efficiency entrapment of superoxide dismutase into cationic liposomes containing synthetic aminoglycolipid. AoK I, H., FUJITA, M., SUN, C., FUJI, K., and MIYAJIMA, K., Chem. Pharm. Bull. (Tokyo), 1997, 45 (8), 1327–1331.
  • Highly sensitive and stable phosphatidylserine liposome aggregation assay for annexins. LEE, G., and POLLARD, H. B., Anal. Biochem., 1997, 252 (1), 160–164.
  • HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma anti-body. TODA, S., ISHII, N., OKADA, E., KUSAKABE, K. I., ARAI, H., HAMAJIMA, K., GORAI, I., NISHIOKA, K., and OKUDA, K., Immunology, 1997, 92(1), 111–117.
  • Immunofluorescence in situ hybridization (IFISH) in neurones retrogradely labelled with rhodamine latex microspheres. SENATOROV, V. V., TRUDEAU, V. L., and Hu, B., Brain. Res. Brain Res. Protoc., 1997, 1(1), 49–56.
  • In vitro and in vivo evaluation of prolonged release microspheres and tablets containing calcitonin gene-related peptide. SATO, Y., KIKUCHI, N., BAMBA, T., KAMINUMA, T., TAJIMA, M., WATABE, K., AHMAD, I., SHIMIZU, H., and YOSHIMOTO, T., Yakuzaigaku, 1997, 57(3), 152–158.
  • In-vitro release characterization of a new liquid theophylline prolonged-release dosage form: sachets with microcapsules for the preparation of a ready-to-use suspension designed for elderly and children. WEI-BETA, G., KLEMM, F., FUCHS, W., STANISLAUS, F., ZEMA, M., and CALANCHI, M., Farm. Vestn. (Ljubljana), 1997, 48 (Pos. Stev.), 246–247.
  • In-vitro zero-order release of anti-inflammatory drugs from pullulan acetate phthalate microspheres. UCHIDA, T., YASUTAKE, T., NISHIKATA, M., NAKAI, A., KONISIII, Y., NAGAREYA, N., and MATSUYAMA, K., Pharm. Sci., 1997, 3(8), 387–390.
  • Incorporation of nitric oxide-releasing crosslinked polyethyleneimine microspheres into vascular grafts. PULFER, S. K., Orr, D., and SMITH, D. J., y. Biomed. Mater. Res, 1997, 37(2), 182–189.
  • Increased-durability epoxy coating modified with glass microspheres. KOTNAROWSKA, D., Przegl Spatval, 1997, 49(9-10), 13–17.
  • Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine. OKAMOTO, T., KANEDA, Y., YUZUKI, D., HUANG, S. K., CHI, D. D., and HOON, D. S., Gene. Ther., 1997, 4 (9), 969–976.
  • Induction of autoimmune prostatitis using liposomes is associated to peritoneal cells activa-tion. IRIBARREN, P., CORREA, S. G., and RIERA, C. M., Am. y. Reprod. Immunol., 1997, 38(5), 343–349.
  • Influence of liposome composition and size on the transport of encapsulated substances into the skin studied by EPR methods. VRHOVNIK, K., KRISTL, J., SENTJURC, M., and SMID-KORBAR, J., Farm. Vestn. (Ljubljana), 1997, 48 (Pos. Stev.), 324–325.
  • Influence of calcium on dextran induced liposome aggregation. BARINCOVA, M., and MACFIOVA, E., Pharmazie, 1997, 52(12), 960–961.
  • Inhibition of mouse mammary carcinoma development with doxorubicin in liposomes. VAAGE, J., WORKING, P., and USTER, P., /nt..7. Cancer, 1998, 75(1), 158–159.
  • Initiation by iron-chelates of xanthine oxidase-dependent lipid peroxidation in liposomes. Characterization of effect of ferric-nitrilotriacetate (Fe3 + -NTA). FUKUZAWA, K., GONDOH, N., TOKUMURA, A., UENO, S., and SHIBATA, A., Fun i Rajikaru no Rinsho, 1997, 12, 70–76.
  • Interaction of apolipoprotein model peptides with liposomes: a high performance liquid chromatography study. WANG, Q., Cui, D., and LIN, Q., Shengtvu Huaxue Yu Shengtvu Wuli Xuebao, 1997, 29(2), 150–156.
  • Interaction of spermine with dimyristoyl-L-alpha-phosphatidyl-ra-glycerol multilamellar liposomes. STEVANATO, R., WISNIEWSKA, A., and Momo, F., Arch. Biochem. Biophys., 1997, 346(2), 203–207.
  • Interaction of synthetic peptide corresponding to signal sequence of glucitol permease of Escherichia coli and its analogue with liposomes. WANG, Q., Cul, D., and LIN, Q., Sci. China C. Life Sci., 1996, 39(4), 395–405.
  • Interaction of apolipoprotein A-I model peptides with liposomes. WANG, Q., Cut, D., and LIN, Q., Shengtvu Huaxue Yu Shengtvu Wuli Xuebao, 1997, 29(1), 8–16.
  • Interaction of DMPC liposomes with a DMPA monolayer: related study of Langmuir-Blodgett films. LEONARD, L. M., MOREL'S, R. M., and COULET, P. R., Supramol. Sci., 1997, 4(3-4), 357–363.
  • Interactions between cationic liposomes and an antigenic protein: the physical chemistry of the immunoadjuvant action. TSURUTA, L. R., QUINTILIO, W., COSTA, M. H., and CARMONA RIBEIRO, A. M.,.7. Lipid. Res., 1997, 38(10), 2003–2011.
  • Kinetics and role of alpha 1-acid glycoprotein-dependent osmotic transport of water and ions in palmitoyl-L-oleoyl phosphatidylcholine liposomes. NEITCHEV, V., KOSTOVA, E., GOLD-ENBERG, M., and DOUMANOVA, L., Int. y. Biochem. Cell. Biol., 1997, 29(4), 689–701.
  • Kinetics of radiation-, and cytochrome c-induced modifications in liposomes analysed by FT. Raman spectroscopy. SAILER, K., VIAGGI, S., and Nusss, M., Biochim. Biophys. Acta, 1997, 1329 (2), 259–268.
  • L-arginine transport in cultured vascular smooth muscle cells of spontaneously hypertensive rats and effect of liposome on the transport. YAO, X., Lu, X., ZHANG, L., Niu, D., GAO, L., PANG, Y., Su, J., and TANG, C., Shengli Xuebao, 1997, 49(1), 67–72.
  • Lipopolysaccharide and liposome-encapsulated MTP-PE-induced cytotoxicity and release of eicosanoids, tumor necrosis factor- alpha and nitric oxide in liver macrophages. DIETER, P., AMBS, P., FITZKE, E., and ScHwENDE, H., Adv. Exp. Med. Biol., 1997, 407, 485–490.
  • Liposomal thyroxine: a noninvasive model for transplacental fetal therapy. BAJORIA, R., FISK, N. M., and CONTRACTOR, S. F., J. Clin. Endocrinol. Metab., 1997, 82(10), 3271–3277.
  • Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. LEENDERS, A. C., REISS, P., PORTEGIES, P., CLEZY, K., HOP, W. C., Hoy, J., BORLES, J. C., ALLWORTH, T., KAUMANN, R. H., JONES, P., KROON, F. P., VERBRUGH, H. A., and DE MARIE, S., AIDS, 1997, 11(12), 1463–1471.
  • Liposomal formulations of chemotherapeutic drugs. BERNAL, S. D., WONG, Y. C., DE VILLA, R., and BERNAS, G., Basic Clin. Oncol., 1997, 13 (Drug Resistance in Oncology), 87–106.
  • Liposome technology: dehydration-rehydration vesicles and their application in drug and vaccine delivery. GREGORIADIS, G., MCCORMACK, B., PERRIE, Y., SAFFIE, R., and ZADI, B., Farm. Vestn. (Ljubljana), 1997, 48 (Pos. Stev.), 228–229.
  • Liposome fusion. BAILEY, A. L., and Cuu.is, P. R., Curr. Top. Membr., 1997, 44 (Lipid Polymorphism and Membrane Properties), 359–373.
  • Liposome mediated gene transfer into the rat oesophagus. SCHMID, R. M., WEIDENBACH, H., DRAENERT, G. F., LIPTAY, S., LUEIRS, H., and ADLER, G., Gut, 1997, 41(4), 549–556.
  • Liposome uptake by human retinal pigment epithelial cells in culture. NIESNIAN, M. R., PEYMAN, G. A., and MICELI, M. V., Curr. Eye. Res., 1997, 16(11), 1073–1080.
  • Liposome-entrapped dichloromethylene diphosphonate induces apoptosis in Kupffer cells. NAITO, M., NAG Al, H., KAWANO, S., UMEZU, H., ZHU, H., MORIYAMA, H., YAMAMOTO, T., TAKATSUKA, H., and TAKE, Y., Cells Hepatic Sinusoid, 1997, 6, 251–254. 1996.
  • Liposome-mediated gene delivery. KANEDA, Y Tanpakushitsu. Kakusan. Koso., 1997, 42(10 Suppl), 1806–1813. 24 Refs.
  • Liposome-mediated gene transfer to lung isografts. BOASQUEVISQUE, C. H., LEE, T. C., MORA, B. N., PETERSON, D., OSBURN, W. 0., BERNSTEIN, M., ZHANG, W., NIETUPSKI, J. B., SCHEULE, R. K., COOPER, J. D., BoTNEv, M. D., and PATTERSON, G. A., y. Thorac. Cardiovasc. Surg., 1997, 114(5), 783–791; discussion 791–792.
  • Liposomes containing DOPA prevent the neuronal damage in the substantia nigra and decrease lipid peroxidation level in the striatum of mice with experimental Parkin-sonian syndrome. KLICHERYANU, V. G., YARASOV, V. V., KRYZHANOVSKY, G. N., BORDIUKOV, M. M., ZHIGALTSEV, I. V., NIKUSHKIN, E. V., KAPLLTN, A. P., and SHVETS, V. I., Farm Vestn ( Ljubljana), 1997, 48 (Pos. Stev.), 322–323.
  • Liposomes. Opportunities in drug delivery. ALLEN, T. M., Drugs, 1997, 54 (Suppl. 4, Disease Management of Solid Tumours and the Emerging Role of Pegylated Liposomal Doxorubicin), 8–14.
  • Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: III. Influ-ence of surface modification with poly (ethyleneglycol). OUSSOREN, C., and STORNI, G., Pharm. Res., 1997, 14(10), 1479–1484.
  • Magnetic microspheres for drug targeting. CHENG, D., and TANG, M., Shaanxi Yixue Zazhi, 1995, 24(2), 104–107.
  • Magnetofluorescent liposomes for increased sensitivity of immunofluorescence. SCHEFFOLD, A., MILTENYI, S., and RADBRUCH, A., Immunotechnology, 1995, 1(2), 127–137.
  • Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells. KAMPS, J. A., MoRsEur, H. W., SWART, P. J., MEIJER, D. K., and SCHERPHOF, G. L., Proc. Natl. Acad. Sci. U.S.A., 1997, 94(21), 11 681–11 685.
  • Mechanism of adenovirus improvement of cationic liposome-mediated gene transfer. MEUNIER DURMORT, C., PICART, R., RAGOT, T., PERRICAUDET, M., HAINQUE, B., and FOREST, C., Biochim. Biophys. Acta, 1997, 1330(1), 8–16.
  • Membrane fusion activity of Semliki Forest virus in a liposomal model system: specific inhibition by Zn2 + ions. CORVER, J., BRON, R., SNIPPE, H., KRAAIJEVELD, C., and WILSCHUT, J., Virology, 1997, 238 (1), 14–21.
  • Microencapsulation of human insulin DEAE-dextran complex and the complex in liposomes by the emulsion non-solvent addition method. MANOSROI, A., and MANOSROI, J., J. Microencapsul., 1997, 14(6), 761–768.
  • Microencapsulation of pyrrolnitrin from Pseudomonas cepacia using gluten and casein. Yu, J. Y., and LEE, W. C., J. Ferment. Bioeng., 1997, 84(5), 444–448.
  • Microencapsulation of antigens using biodegradable polyesters: facts and phantasies. KISSEL, T., KONEBERC;, R., HILBERT, A. K., and HUNGERER, K. D., Behring. Inst. Mitt., 1997, (98), 172–183. 30 Refs.
  • Microencapsulation and oxidative stability of docosahexaenoic acid. CHANG, P. S., ACS Symp. Ser., 1997, 674 (Flavor and Lipid Chemistry of Seafoods), 264–273.
  • Microspectroscopic analyses of dye distribution characteristics in single microcapsules. Kim, H. B., YOSHIDA, S., MIURA, A., and KITAMURA, N., Anal. Chem., 1998, 70(1), 111–116.
  • Microspheres by dispersion polymerization of lactides and s-caprolactone. SLOMKOWSKI, S., SOSNOWSKI, S., and GADZINOWSKI, M., Macromol. Symp., 1997, 123 (37th Microsymposium on Macromolecules (Bio) degradable Polymers: Chemical, Biological and Environmental Aspects, 1996), 45–60.
  • Mismatch of duodenal deliveries of dietary fat and pancreatin from enterically coated microspheres. MEYER, J. H., and LAKE, R., Pancreas, 1997, 15(3), 226–235.
  • Modified polyacrylamide microspheres as immunosorbent. PANIKKAR, B., HARI, P. R., and SHARMA, C. P., Artif. Cells, Blood Substitutes, Immobilization Biotechnol., 1997, 25(6), 541-550. Multilamellar structures of DNA complexes with cationic liposomes. DAN, N., Biophys. y., 1997, 73(4), 1842–1846.
  • Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides. COUVREUR, P., BLANCO, P. M. J., PUISIEUX, F., ROQUES, B., and FATTAL, E., Adv. Drug Delivery Rev., 1997, 28(1), 85–96.
  • Nebulized interleukin 2 liposomes: aerosol characteristics and biodistribution. KHANNA, C., WALDREP, J. C., ANDERSON, P. M., WEISCHELBAUM, R. W., HASZ, D. E., KATSANIS, E., and KLAUSNER, J. s., J. Pharm. Pharmacol., 1997, 49(10), 960–971.
  • Neurotoxicological assessment after intracisternal injection of liposomal bupivacaine in rabbits. MALINOVSKY, J. M., BENHAMOU, D., ALAFANDY, M., MUSSINI, J. M., COUSSAERT, C., COUARRAZE, G., PINAUD, M., and LEGROS, F. J., Anesth. Analg., 1997, 85(6), 1331–1336.
  • New fluorescent lysolipids: preparation and selective labeling of inner liposome leaflet. RAZINKOV, V. I., HERNANDEZ JIMENEZ, E. I., MIKHALYOV, I. I., COHEN, F. S., and MOLOTKOVSKY, J. G., Biochim. Biophys. Acta, 1997, 1329(1), 149–158.
  • New advances in microsphere-based single-dose vaccines. HANES, J., CLELAND, J. L., and LANGER, R., Adv. Drug Delivery Rev., 1997, 28(1), 97–119.
  • New synthetic polymers for enzyme and liposome modification. VERONESE, F. M., CALICETI, P., and SCHIAVON, 0., ACS Symp. Ser., 1997, 680 (Poly(ethylene glycol)), 182-192. Non-isothermal flow diagnostics using microencapsulated cholesteric particles. WOZNIAK, G., WOZNIAK, K., and SIEKMANN, J., Appl. Sci. Res., 1996, 56(23), 145–156.
  • Nonimmune phagocytosis of liposomes by rat alveolar macrophages is enhanced by vitro-nectin and is vitronectin-receptor mediated. PERRY, D. G., WISNIOWSKI, P., DAUGHERTY, G. L., DOWNING, J., and MARTIN, W. J. 2ND. Am. J. Respir. Cell. Mol. Biol., 1997, 17(4), 462–470.
  • Novel laser-induced ejection phenomenon of single polymeric microspheres. FultumoTo, H., FUKUMURA, H., and MASUHARA, H., Reza Kenkyu, 1997, 25 (11), 748–753.
  • One- and three-month release injectable microspheres of the LH-RH superagonist leu-prorelin acetate. OKADA, H., Adv. Drug Delivery Rev., 1997, 28(1), 43–70.
  • Oral delivery of insulin by using surface coating liposomes. Improvement of stability of insulin in GI tract. IWANAGA, K., ONO, S., NARIOKA, K., MoRimoTo, K., KAKEMI, M., YAMASHITA, S., NANGO, M., and OKU, N., Int. J. Pharm., 1997, 157 (1), 73–80.
  • Oral delivery and fate of poly(lactic acid) microsphere-encapsulated interferon in rats. EYLES, J. E., ALEAR, H. 0., CONWAY, B. R., and KESWICK, M., J. Pharm. Pharmacol., 1997, 49(7), 669–674.
  • Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. YANG, J. P., and HUANG, L., Gene Ther., 1997, 4(9), 950–960.
  • Oxidative stability of liposomes prepared from soybean PC, chicken egg PC, and salmon egg PC. NARA, E., MIYASHITA, K., and OTA, T., Biosci., Biotechnol., Biochem., 1997, 61(10), 1736–1738.
  • Pattern recognition and quantitative characterization of surface morphology of micro-capsulized pigment particles. YANG, G. Q., Guo, C. R., WANG, X. S., Cut, J. Z., YAN, L. M., and ZHANG, W. D., Gaodeng Xuexiao Huaxue Xuebao, 1997, 18(11), 1897–1898.
  • Permeation control of polymerized liposome. CHUNG, Y. C., Bull. Korean Chem. Soc., 1997, 18(10), 1041–1043.
  • pH sensitivity and plasma stability of liposomes containing N-stearoylcysteamine. CAZZOLA, R., VIANI, P., ALLEVI, P., CIGHETTI, G., and CESTARO, B., Biochim. Biophys. Acta, 1997, 1329 (2), 291–301.
  • Pharmacokinetics and retinal toxicity of intravitreal liposome-encapsulated 5-fluorouridine. GARCIA-ARUMI, J., PASCUAL, R., FONSECA, M. J., ISART, F. R., CASAROLI, R., MATEO, C., and CORCOSTEGUI, B., Ophthalmologica, 1997, 211 (6), 344–350.
  • Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs. VALLADARES, J. E., FREIXAS, J., ALBEROLA, J., FRANQUELO, C., CRISTOFOL, C., and ARBmx, M., Am. y. Trop. Med. Hyg., 1997, 57(4), 403–406.
  • Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-liposome complexes. Hui, K. M., ANG, P. T., HUANG, L., and TAY, S. K., Gene They., 1997, 4(8), 783–790.
  • Physical characteristics and lipoprotein distribution of liposomal nystatin in human plasma. WASAN, K. M., RAMASWAMY, M., CASSIDY, S. M., KAZEMI, M., STROBEL, F. W., and THIES, R. L., Antimicrob. Agents Chemother., 1997, 41(9), 1871–1875.
  • Physicochemical properties and in vitro toxicity of cationic liposome cDNA complexes. SCHREIER, H., GAGNE, L., BOCK, T., ERDOS, G. W., DRUZGALA, P., CONARY, J. T., and MULLER, B. W Pharm. Acta. Hely., 1997, 72(4), 215–223.
  • Platelet reactivity with liposome-encapsulated hemoglobin in the rat. PHILLIPS, W. T., KLIPPER, R., FRESNE, D., RUDOLPH, A. S., JAvoas, M., and GOINS, B., Exp. Hematol., 1997, 25(13), 1347–1356.
  • Poly(ethylene glycol)-grafted liposome therapeutics. WOODLE, M. C., ACS Symp. Ser., 1997, 680 (Poly(ethylene glycol)), 60–81.
  • Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumors. GABIZON, A., and MARTIN, F., Drugs, 1997, 54 (Suppl. 4, Disease Management of Solid Tumours and the Emerging Role of Pegylated Liposomal Doxorubicin), 15–21.
  • Polymer microsphere and polymer-ferrite nanocomposite preparation by precipitation from water-in-oil microemulsions. BANERJEE, S., JOHN, V. T., MCPHERSON, G. L., O'CoNoa, C. J., BUISSON, Y. S. L., AKKARA, J. A., and KAPLAN, D. L., Colloid Polym. Sci., 1997, 275 (10), 930–937.
  • Polymerase chain reaction in liposomes. OBERFIOLZER, T., ALBRIZIO, M., and Luisi, P. L., Chem. Biol., 1995, 2(10), 677–682.
  • Polymeric microencapsulated drug delivery system. Lu, Z., and WANG, S., Gongneng Gaofenzi Xuebao, 1997, 10(3), 429–435.
  • Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. NAKANISHI, T., KUNISAWA, J., HAYASHI, A., TSUTSUMI, Y., KUBO, K. NAKAGAWA, S., FUJIWARA, H., HAMAOKA, T., and MAYUMI, T., Biochem. Biophys. Res. Commun., 1997, 240(3), 793–797.
  • Preparation and evaluation of floating microspheres by core solubilization technique. MURTHY, S. N., Indian Drugs, 1997, 34(11), 674–675.
  • Preparation and characterization of polylactic acid microspheres containing bovine insulin by a w/o/w emulsion solvent evaporation method. UCHIDA, T., NAGAREYA, N., SAKAKIBARA, S., KONISHI, Y., NAKAI, A., NISHIKATA, M., MATSUYAMA, K., and YOSHIDA, K., Chem. Pharm. Bull. (Tokyo), 1997, 45(9), 1539–1543.
  • Preparation and protein encapsulation of micron size ether-ester block copolymer micro- spheres. LI, X., XIAO, J., DENG, X., and JiA, W., Gaofenzi Xuebao, 1997, (5), 543–548.
  • Preparation of calcium-loaded liposomes and their use in calcium phosphate formation. MEssrasmrru, P. B., and STARER, S., Chem. Mater., 1998, 10(1), 109–116.
  • Preparation of polymeric microspheres by the solvent evaporation method using sucrose stearate as a droplet stabilizer. YUKSEL, N., and BAYKARA, T., Y. MicroencapsuL, 1997, 14(6), 725–733.
  • Preparation of thermo-sensitive magnetic hydrogel microspheres and application to enzyme immobilization. Kum)°, A., and FUKUDA, H., J. Ferment. Bioeng., 1997, 84(4), 337–341.
  • Preparation and properties of intestinal juice soluble glycoprotein B microcapsules. ZHU, R., and Norway, H. M., Gongneng Gaofenzi Xuebao, 1997, 10(3), 404–407.
  • Preparation of large magnetic polymer microspheres. Qiu, G., and Qui, G., Yingyong Huaxue, 1997, 14(5), 74–76.
  • Preparation of liposomes of superoxide dismutase. ZHANG, X., SUN, Z., DING, X., LIN, Z., WANG, G., SONG, X., and ZHANG, G., Shengwu Yixue Gongchengxue Zazhi, 1997, 14 (3), 259–262.
  • Preparation of microspheres by the solvent evaporation technique. O'DoNNELL, P. B., and Mc:GIN:Fry, J. W., Adv. Drug Delivery. Rev., 1997, 28(1), 25–42.
  • Preparation of tinidazole microcapsules. FENG, W., and MENG, S., Zhongguo Kangshengsu Zazhi, 1997, 22(2), 90–92.
  • Preparative studies on praziquantel microcapsules. Lu, B., ZnoNc;, H., and YANG, H., Zhongguo Yiyao Gongye Zazhi, 1997, 28(4), 159–161.
  • Progress and application of microencapsulation. FE, S., HE, S., and CAI, J., Huagong Shikan, 1996, 10(12), 8–11.
  • Protection against verocytotoxin in mice induced by liposome-coupled verocytotoxin. NA [To, S., Holum), A., KOMIYA, T., FUKUDA, Y., TAKAHASHI, M., AM, Y., SUZAKI, Y., SATOH, S., GONDAIRA, F., SUGIYAMA, J., NAKANO, Y., MORI, M., AWAI, K., NISHINOHARA, S., and KOMURO, K., Int. Arch. Allergy Immunol., 1997, 114(3), 293–297.
  • Quantitative observation of transmutation products occurring in thin-film coated micro-spheres during electrolysis. MILEY, G. H., NAME, G., WILLIAMS, M. J., PATTERSON, J. A., Nix, J., CRAVENS, D., and HouA, H., Cold Fusion, 1996, 20, 71–84.
  • Quantum efficiency and spatial resolution of microsphere plates stacked with microchannel plates. TREMSIN, A. S., JELINSKY, S. R., and SIEGMUND, 0. H. W., Proc. SPIE-Int. Soc. opt. Eng., 1997, 3114 (EUV, X-Ray, and Gamma-Ray Instrumentation for Astronomy VIII), 272–282.
  • Rabbit spinal cord infarctuated upon aluminum(III)-liposomes intravenous treatment. ZA'rEA, P., ZAMBENEDETTI, P., GIORDANO, R., and FAVARATO, M., I. Trace. Elem. Med. Biol., 1997, 11(3), 170–172.
  • Rapid hepatocyte spheroid formation: optimization and long-term function in perfused microcapsules. SURAPANENI, S., PRYOR, T., KLEIN, M. D., and MATTHEW, H. W., ASAIO 1997, 43(5), M848—M853.
  • Rapid diagnostic imaging of cancer using radiolabeled liposomes. OGIHARA, U. I., SASAKI, T., TOYAMA, H., ODA, K., SENDA, M., and NISHIGORI, H., Cancer. Detect. Prey., 1997, 21 (6), 490–496.
  • Recent trends in drug delivery systems: liposomal drug delivery system-preparation and characterization. CHANDRAN, S., MISHRA, A. R., and MISHRA, B., Indian 7. Exp. Biol., 1997, 35(8), 801–809.
  • Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formula-tion development. CLELAND, J. L., JOHNSON, 0.-F. L., PUTNEY, S., and JONES, A. J. S., Adv. Drug Delivery. Rev., 1997, 28(1), 71–84.
  • Recombinant CF detection in CF tracheal epithelial cells following in vitro liposome-mediated gene transfer. Cowsimo, A., SCARPINO, S., SANGIUOLO, F., Di SARIO, S., MOSSA, G., NOVELL, G., and DALLAPICCOLA, B., Biochem. Mol. Biol. Int., 1997, 42 (4), 723–729.
  • Refolding of carbonic anhydrase assisted by 1-palmitoy1-2-oleoyl-sn-glycero-3-phosphocho-line liposomes. KuBoi, R., YOSHIMOTO, M., WALDE, P., and Luisi, P. L., Biotechnol. Prog., 1997, 13(6), 828–836.
  • Relationship between size of injected microspheres and ultrasound imaging of heart by PLSR. DYRSTAD, K., and SONTUM, P. C., Pharm.-Res., 1997, 14(10), 1485–1489.
  • Remarkable inhibitory effects of hybrid liposomes on the growth of HL-60 cells coupled to induction of apoptosis. IMAMURA, C., KEMURA, Y., MATSUMOTO, Y., and UEOKA, R., Biol. Pharm. Bull., 1997, 20(10), 1119–1121.
  • Repopulation of Kupffer cells in mice after injection of liposome-encapsulated dichloro-methylene diphosphonate. YAMAMOTO, T., NAITO, M., MORIYAMA, H., and Umezu, H., Cells Hepatic Sinusoid, 1997, 6, 71-74, 1996.
  • Rifampicin carrying polyhydroxybutyrate microspheres as a potential chemoembolization agent. KASSAB, A. C., Xu, K., DENKBACS, E. B., Dou, Y., ZHAO, S., and PICSKIN,Biomater.Sci. Polym. Ed., 1997, 8(12), 947–961.
  • RPE65, the major retinal pigment epithelium microsomal membrane protein, associates with phospholipid liposomes. TsiLou, E., HAMEL, C. P., Yu, S., and REDMOND, T. M., Arch. Biochem. Biophys., 1997, 346(1), 21–27.
  • Safety aspects of pegylated liposomal doxorubicin in patients with cancer. ALBERTS, D. S., and GARCIA, D. J., Drugs, 1997, 54 (Suppl. 4, Disease Management of Solid Tumours and the Emerging Role of Pegylated Liposomal Doxorubicin), 30–35.
  • Separation and quantitation of cationic liposome components by high performance liquid chromatography with evaporative light-scattering detection. FELGNER, J. H., Pharm. Res., 1997, 14(9), 1269–1271.
  • Some factors for the preparation of medical therapy glass microspheres by sol-gel process. ZHOU, N., QIAN, D., and HUANG, W., Boli Yu Tangci, 1997, 25(1), 1–5. 11.
  • Spherical cavity-mode laser with self-organized CuCl microspheres. NAGAI, M., HOSHINO, F., YAMAMOTO, S., SHIMANO, R., and KUWATA, G. M., Opt. Lett., 1997, 22(21), 1630–1632.
  • Stability of association of 1-0-octadecy1-2-0-methyl-sn-glycero-3-phosphocholine with lipo-somes is composition dependent. MAYHEW, E., AHMAD, I., BHATIA, S., DAUSE, R., FILEP, J., JANo, A. S., KAISHEVA, E., PERKINS, W. R., ZHA, Y., and FRANKLIN, J. C., Biochim. Biophys. Acta, 1997, 1329(1), 139–148.
  • Stability studies of liposomes as a function of lipid composition, liposomal type, surface charge and storage conditions. ABU, Z. S. S., Zagazig y. Pharm. Sci., 1996, 5(2), 41–48.
  • Stability of liposomes prepared by polyol dilution method. PAVELIC, Z., SKALKO, N., and JALSENJAK, I., Farm Vestn (Ljubljana), 1997, 48 (Pos. Stev.), 318–319.
  • Stabilization of liposomes attached to polymer surfaces having phosphorylcholine groups. IWASAKI, Y., TANAKA, S., HARA, M., ISHIHARA, K., and NAKABAYASHI, N., y. Colloid Interface Sci., 1997, 92(2), 432–439.
  • Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles. SHENDEROVA, A., BURKE, T. G., and SCHWENDEMAN, S. P., Pharm. Res., 1997, 14(10), 1406–1414.
  • Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. MOK, K. W., and Onus, P. R., Biophys. y., 1997, 73(5), 2534–2545.
  • Studies on preparation and antitumor effect of interleukin-2 liposomes. PEI, J., YANG, C., YANG, H., and CHEN, M., Zhongguo Shenghua Yaowu Zazhi, 1997, 18(4), 166–169.
  • Study on mitoxantrone albumin microspheres for liver targeting. ZHANG, Z., and QIAN, W., Yaoxue Xuebao, 1997, 32(1), 72–78.
  • Study on self-crosslinking polymer microspheres of acrylates. YAN, C., and CHENC, S., Hubei Daxue Xuebao, Ziran Kexueban, 1997, 19 (3), 271–277.
  • Successful treatment of severe refractory idiopathic thrombocytopenic purpura with liposo-mal dox-orubicin. COSGRIFF, T. M., BLACK, M. L., and STEIN, W. 3RD., Am. y. Hematol., 1998, 57(1), 85–86.
  • Surface charge control of electropermeabilization and glycophorin electroinsertion with 1,2-diacyl-sn-glycero-3-phosphocholine (lecithin) liposomes. RAFFY, S., and TEISSIE, J., Eur. J. Biochem., 1997, 250(2), 315–319.
  • Surface modification of polyanhydride microspheres. GAO, J., NIKLASON, L., ZHAO, X. M., and LANGER, R., J. Pharm. Sci., 1998, 87(2), 246–248.
  • Survival rate improvement in a rat ischemia model by long circulating liposomes containing cytidine-51-diphosphate choline. FRESTA, M., and Pucusi, G., Life Sci., 1997, 61(13), 1227–1235.
  • Synthesis and study of the chromatographic properties of microspherical carboxylic cation exchangers. EMEL YANOV, I. S., and CHERNYKH, G. P., Zh. Prikl. Khim. (S. Peterburg), 1997, 70(8), 1263–1265.
  • Synthetic lipopeptides incorporated in liposomes: in vitro stimulation of the proliferation of murine splenocytes and in vivo induction of an immune response against a peptide antigen. FERNANDES, I., FRISCH, B., MULLER, S., and SCHUBER, F., Mol. Immunol., 1997, 34(89), 569–576.
  • Targeting of liposomes to sinusoidal liver cells: massive uptake by liver endothelial cells via a scavenger receptor mediated process. KAMPS, J. A. A. M., MORSELT, H. W. M., SWART, P. J., MEIJER, D. K. F., and SCHERPHOF, G. L., Cells Hepatic Sinusoid, 1997, 6, 387-388, 1996.
  • The preparation of functional lipid liposomes by `gamma'-ray irradiation and its application. Host:a, F., and AKAMA, K., Hyomen, 1997, 35(11), 598–609.
  • The effect of phospholipid liposomes on atherosclerosis and serum lipid in rabbits. HE, Y., Xu, N., and Liu, X., Chung Hua Nei Ko Tsa Chih, 1996, 35(5), 313–316.
  • The effect of reduced salt content on the function of liposome-encapsulated Neutrase and heat-treated lactobacilli in rindless low-fat cheese. SKEIE, S., NARVHUS, J. A., ARDO, Y., THORVALDSEN, K., and ABRAHAMSEN, R. K., Lait, 1997, 77(5), 575–585.
  • The HVJ-liposome molecular delivery system for in vivo genetic engineering. GIBBONS, G. H., Dev. Cardiovasc. Med., 1997, 189 (Gene Transfer in the Cardiovascular System), 111–141.
  • The immune response to staphylococcal antigens in mice depleted of macrophages by Cl2MDP-liposomes. RUDNICKA, W., WIECKOWSKA, M., VAN ROOIJEN, N., and ROZALSKA, B., Zentralbl. Bakteriol., 1997, 286(4), 511–522.
  • The proton permeability of liposomes made from mitochondrial inner membrane phospho-lipids: no effect of fatty acid composition. BROOKES, P. S., HULBERT, A. J, and BRAND, M. D., Biochim. Biophys. Acta, 1997, 1330(2), 157–164.
  • The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. NILSSON, I. M., LEE, J. C., BREMELL, T., RYDEN, C., and TARKOWSKI, A., Infect. Immun., 1997, 65(10), 4216–4221.
  • The sensitive detection and quantitation of antibody to HCV by using a microsphere-based immunoassay and flow cytometry. McHucu, T. M., VIELE, M. K., CHASE, E. S., and RECKTENWALD, D. J., Cytometry, 1997, 29(2), 106–112.
  • The use of lectins for liposome targeting in drug delivery. KASZUBA, M., and JoNies, M. N., Methods Mol. Med., 1998, 9 (Lectin Methods and Protocols), 583–594.
  • Therapeutic effects of leuprorelin microspheres in prostate cancer. SHARIFI, R., RATANAWONG, C., JUNG, A., Wu, Z., BROWNELLER, R., and LEE, M., Adv Drug Delivery Rev, 1997, 28(1), 121–138.
  • Thermal analysis of freeze-dried liposome-carbohydrate mixtures with modulated tempera-ture differential scanning calorimetry (MTDSC). VAN WINDEN, E. C. A., TALSMA, H., and CROMMELIN, D. J. A., J. Pharm. Sci., 1998, 87(2), 231–237.
  • Thermally triggered calcium phosphate formation from calcium-loaded liposomes. MESSES-SMITH, P. B., and STARKE, S., Chem. Mater., 1998, 10(1), 117–124.
  • Thermoresponsive release from poly(L-lactic acid) microcapsules containing poly(N-isopro-pylacrylamide) gel. KIDCHOB, T., KIMURA, S., and IMANISHI, Y., J. Chem. Soc., 1997, Perkin Trans., 2(11), 2195–2200.
  • Tolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosol. GILBERT, B. E., KNIGHT, C., ALVAREZ, F. G., WALDREP, C., RODARTE, J. R., KNIGHT, V., and ESCHENBACHER, W. L., Am. J. Respir. Crit. Care Med., 1997, 156(6), 1789–1793.
  • Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. FILION, M. C., and PHILLIPS, N. C., Biochim. Biophys. Acta, 1997, 1329(2), 345–356.
  • Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression. TSENG, W. C., HASELTON, F. R., and GIORGIO, T. D., y. Biol. Chem., 1997, 272 (41), 25 641–25 647.
  • Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. RANSON, M. R., CARMICHAEL, J., O'BYRNE, K., STEWART, S., SMITH, D., and HOWELL, A., J. Clin. Oncol., 1997, 15(10), 3185–1391.
  • Ultrasound driven aggregation and surface silanol modification in amorphous silica micro- spheres. RAMESH, S., KOLTYPIN, Y., and GEDANKEN, A., y. Mater. Res., 1997, 12(12), 3271–3277.
  • Upscaling the production of microencapsulated pancreatic islets. DE VOS, P., DE HAAN, B. J., and VAN SCHILFGAARDE, R., Biomaterials, 1997, 18(16), 1085–1090.
  • Use of an automated fluorescent microsphere method to measure regional blood flow in the fetal lamb. TAN, W., RIGGS, K. W., THIES, R. L., and RURAK, D. W., Can. J. Physiol. Pharmacol., 1997, 75(8), 959–968.
  • Use of pro-liposomes as an auxiliary in dyeing of wool and polyester fabrics. ROBERT, P., BARNADAS, R., SAUS, J., LAGUNAS, T., and SABES, M., Rev. Quim. Text, 1997, 134, 16, 18-20, 22.
  • Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms. HIRAI, H., SATOH, E., OSAWA, M., INABA, T., SHIMAZAKI, C., KINOSHITA, S., NAKAGAWA, M., MAZDA, 0., and IMANISHI, J., Biochem. Biophys. Res. Commun., 1997, 241 (1), 112–118.
  • Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres. TAKADA, S., KUROKAWA, T., MIYAZAKI, K., IWASA, S., and OGAWA, Y., Pharm. Res., 1997, 14(9), 1146–1150.
  • Vacuum splitting of energy levels in the atom-dielectric microsphere system. Kumov, V. V., and LETOKHOV, V. S., Zh. Eksp. Teor. Fix., 1997, 111(1), 44–51.
  • Visualization of peptides derived from liposome-encapsulated proteins in the trans-Golgi area of macrophages. RAO, M., ROTHWELL, S. W., WASSEF, N. M., PAGANO, R. E., and ALVING, C. R., Immunol. Lett., 1997, 59(2), 99–105.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.